|
HY-100472-1mL
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-148417-10mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-100mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-25mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-5mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-50mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111838A-10mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-100mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-25mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-5mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-50mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-1mL
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-111838-10mg
|
MedChemexpress LLC
|
ZZW-115 [CAS 801991-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111838-100mg
|
MedChemexpress LLC
|
ZZW-115 [CAS 801991-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111838-5mg
|
MedChemexpress LLC
|
ZZW-115 [CAS 801991-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111838-50mg
|
MedChemexpress LLC
|
ZZW-115 [CAS 801991-87-7]
|
|
Cancer-programmed cell death
|
|
